Company Overview and News
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 18th:
Ternium is riding high on strong volume growth, solid margins, and improving end-market conditions in multiple markets.
Input cost inflation is pressuring margins, but ArcelorMittal's first quarter EBITDA was about 8% better than the Street expected.
Gerdau reported a better-than-expected first quarter, with strong EBITDA growth across the business segments and over 20% margins in Brazil.
Companhia Siderúrgica Nacional (SID - Free Report) or CSN reported impressive financial results for the first quarter of 2018. Net earnings from continuing operations were approximately R$1,486.5 million ($457.4 million), significantly higher than R$117.6 million ($37.5 million) recorded in the year-ago quarter. Earnings per share in the reported quarter were R$1.07 or roughly 33 cents per American Depository Receipt (ADR).
ArcelorMittal (MT - Free Report) saw its profits rise in first-quarter 2018, helped by a spike in steel prices. The steel behemoth logged net income of $1,192 million or $1.17 per share in the reported quarter, up around 19% from $1,002 million or 98 cents a year ago. Revenues went up roughly 19% year over year to $19,186 million in the quarter on the back of higher average steel selling prices and increased steel shipments.
Hi. Good afternoon, everybody. Welcome to ArcelorMittal’s Q1 2018 Analyst and Investor Call. This is Daniel Fairclough from ArcelorMittal Investor Relations team. And I’m joined on this call today by Genuíno Christino, who’s our Head of Finance.
Bpost's share price has been under pressure due to the light results, and an overambitious acquisition in the U.S.
ArcelorMittal SA (ADR) (NYSE:MT) stock was up on Friday following the release of its earnings report for the first quarter of 2018.
The following slide deck was published by ArcelorMittal in conjunction with their 2018 Q1 earnings call.
ArcelorMittal (NYSE: MT) reported first-quarter results before European markets opened Friday. The steelmaker reported basic earnings per share of $1.17 on revenues of $19.19 billion. Net profit for the quarter totaled $1.19 billion, compared to net profit a year ago of $1.00 billion. In the same period last year, the company reported basic EPS of $0.98 and sales of $16.09 billion. Analysts at FactSet had forecast net profit of $940 million on sales of $18.
Gerdau S.A. reported impressive results for first-quarter 2018. The Brazilian steel maker’s adjusted net income totaled R$451.1 million ($138.8 million) in the reported quarter versus net loss of R$34.146 ($10.9 million) incurred in the year-ago quarter. The bottom line benefited from higher revenue generation, rise in adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) and fall in financial expenses.
The world's largest steelmaker ArcelorMittal has hired Bank of America-Merrill Lynch to sell a number of its steel assets to secure antitrust clearance to acquire Italian peer Ilva.
London: The world’s largest steelmaker ArcelorMittal has hired Bank of America-Merrill Lynch to sell a number of its steel assets to secure antitrust clearance to acquire Italian peer Ilva.
Chicago, IL – May 9, 2018 – Today, Zacks Equity Research discusses the Steel, including Nucor Corp. (NUE - Free Report) , Commercial Metals Company (CMC - Free Report) , ArcelorMittal (MT - Free Report) and Steel Dynamics Inc. (STLD - Free Report) .
19h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
20h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...